Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer.


Oral chemotherapy is the preferred treatment for colon cancer. However, this strategy faces many challenges, including instability in the gastrointestinal (GI) tract, insufficient bioavailability, low tumor targeting, and severe adverse effects. In this study, we designed a novel redox nanoparticle (RNP(O)) that is an ideal oral therapeutics for colitis… (More)
DOI: 10.1016/j.biomaterials.2015.03.037


6 Figures and Tables


Citations per Year

Citation Velocity: 12

Averaging 12 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.